Bijan Almassian

Cofounder, President & CEO

Professional Overview
Bijan Almassian is a seasoned biopharmaceutical executive with over 30 years of experience in drug development, operations, and entrepreneurship. As the Cofounder, President and CEO of CaroGen Corporation, he leverages his extensive expertise to drive the company's mission of developing innovative immunotherapies for the treatment of cancer and infectious diseases.

Experience Summary

Current Role
As the Cofounder, President and CEO of CaroGen Corporation, Bijan is responsible for the overall strategic direction and operational management of the company. Under his leadership, CaroGen has advanced multiple novel vaccine and immunotherapy candidates through preclinical development and into clinical trials, with a focus on addressing unmet medical needs in oncology and infectious diseases. Bijan's strategic vision and operational acumen have been instrumental in securing significant funding and partnerships to support CaroGen's growth and development.

Career Progression
Prior to co-founding CaroGen, Bijan held key leadership positions at various biopharmaceutical companies, including serving as the Chairman and Founder of Aria Neruosciences, Inc., the President and CEO of ExSAR Corporations, and the COO of Panacea Pharmaceuticals. He also held senior roles in drug development at Vion Pharmaceuticals, Inc. and Genelabs Technologies, Inc., where he played a pivotal role in advancing drug candidates through the development pipeline.

Academic Background
Bijan holds a Ph.D. in Biochemistry from Boston University, where he also completed his postdoctoral fellowship. His academic training and research experience have provided a strong foundation for his work in the biopharmaceutical industry.

Areas of Expertise
Bijan's areas of expertise include drug development, clinical trial design and execution, regulatory affairs, business development, and strategic planning. He has a proven track record of successfully navigating the complex landscape of the biopharmaceutical industry and delivering innovative solutions to address unmet medical needs.

Professional Impact
Throughout his career, Bijan has been instrumental in the development and advancement of several drug candidates, resulting in the approval and commercialization of novel therapies. His leadership and technical expertise have been recognized by his peers, and he has contributed to the industry through publications, presentations, and advisory roles.

Conclusion
With his extensive experience, strategic vision, and unwavering commitment to innovation, Bijan Almassian is poised to continue driving the success of CaroGen Corporation and making a significant impact on the biopharmaceutical industry.